IPO market passes first test of 2017 but French election fears worry some

By Aidan Gregory
06 Apr 2017

Bankers are pleased that the first IPO season of 2017 has passed without any major problems, but the next window, in May and June, promises to be far more challenging, with all the uncertainty surrounding the French election. It could cause the flow of IPOs to stutter, but a positive outcome could also provide some upside.

Galenica Santé, Gestamp, Farmafactoring, Dino Polska, X-Fab and UniEuro all priced their IPOs successfully this week. 

All the other large deals that were completed earlier in March — such as Neinor Homes, Prosegur Cash, Ambea and BioPharma Credit — all won strong demand and have traded well in ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.